Literature DB >> 23159950

The role and regulation of human Th17 cells in tumor immunity.

Jian Ye1, Rob S Livergood, Guangyong Peng.   

Abstract

T helper 17 (Th17) cells play critical roles in the pathogenesis of inflammatory and autoimmune diseases, as well as in host protection against pathogens. The contribution of Th17 cells to human tumor immunity, however, remains largely unknown. Since their identification in 2005, Th17 cells have been extensively studied in mouse tumor models and human cancer patients. Although accumulating data suggest the importance of Th17 cells to tumor immunity, conclusions regarding the functional role of Th17 cells remain controversial. In this review, we summarize current knowledge regarding the regulation and functional role of Th17 cells in human cancers. In particular, we emphasize several recently identified characteristics of Th17 cells, including plasticity, their relationship with regulatory T cells, and Th17 cell heterogeneity in the tumor microenvironment. Improved understanding of these issues is critical to elucidating the role of Th17 cells in antitumor immunity and for the design of novel therapeutic approaches specifically targeting Th17 cells.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23159950      PMCID: PMC3532708          DOI: 10.1016/j.ajpath.2012.08.041

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  83 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Interleukin-17 promotes angiogenesis and tumor growth.

Authors:  Muneo Numasaki; Jun-ichi Fukushi; Mayumi Ono; Satwant K Narula; Paul J Zavodny; Toshio Kudo; Paul D Robbins; Hideaki Tahara; Michael T Lotze
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

3.  Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.

Authors:  Eric V Dang; Joseph Barbi; Huang-Yu Yang; Dilini Jinasena; Hong Yu; Ying Zheng; Zachary Bordman; Juan Fu; Young Kim; Hung-Rong Yen; Weibo Luo; Karen Zeller; Larissa Shimoda; Suzanne L Topalian; Gregg L Semenza; Chi V Dang; Drew M Pardoll; Fan Pan
Journal:  Cell       Date:  2011-08-25       Impact factor: 41.582

4.  Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.

Authors:  Fabrice Benchetrit; Arnaud Ciree; Virginie Vives; Guy Warnier; Alain Gey; Catherine Sautès-Fridman; François Fossiez; Nacilla Haicheur; Wolf H Fridman; Eric Tartour
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

5.  Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients.

Authors:  Evelyna Derhovanessian; Victoria Adams; Karin Hähnel; Andrea Groeger; Hardev Pandha; Stephen Ward; Graham Pawelec
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

6.  T helper 17 cells promote cytotoxic T cell activation in tumor immunity.

Authors:  Natalia Martin-Orozco; Pawel Muranski; Yeonseok Chung; Xuexian O Yang; Tomohide Yamazaki; Sijie Lu; Patrick Hwu; Nicholas P Restifo; Willem W Overwijk; Chen Dong
Journal:  Immunity       Date:  2009-10-29       Impact factor: 31.745

7.  Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia.

Authors:  C Wu; S Wang; F Wang; Q Chen; S Peng; Y Zhang; J Qian; J Jin; H Xu
Journal:  Clin Exp Immunol       Date:  2009-08-11       Impact factor: 4.330

8.  Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.

Authors:  Ilona Kryczek; Mousumi Banerjee; Pui Cheng; Linhua Vatan; Wojciech Szeliga; Shuang Wei; Emina Huang; Emily Finlayson; Diane Simeone; Theodore H Welling; Alfred Chang; George Coukos; Rebecca Liu; Weiping Zou
Journal:  Blood       Date:  2009-05-21       Impact factor: 22.113

9.  Type 17 CD8+ T cells display enhanced antitumor immunity.

Authors:  Christian S Hinrichs; Andrew Kaiser; Chrystal M Paulos; Lydie Cassard; Luis Sanchez-Perez; Bianca Heemskerk; Claudia Wrzesinski; Zachary A Borman; Pawel Muranski; Nicholas P Restifo
Journal:  Blood       Date:  2009-05-26       Impact factor: 22.113

10.  The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.

Authors:  Kellie A Charles; Hagen Kulbe; Robin Soper; Monica Escorcio-Correia; Toby Lawrence; Anne Schultheis; Probir Chakravarty; Richard G Thompson; George Kollias; John F Smyth; Frances R Balkwill; Thorsten Hagemann
Journal:  J Clin Invest       Date:  2009-09-08       Impact factor: 14.808

View more
  61 in total

1.  Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis.

Authors:  Zhaoliang Su; Yingkun Sun; Haitao Zhu; Yueqin Liu; Xin Lin; Huiling Shen; Jianguo Chen; Wenlin Xu; Huaxi Xu
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 2.  Towards tumor immunodiagnostics.

Authors:  Helen Kourea; Vassiliki Kotoula
Journal:  Ann Transl Med       Date:  2016-07

Review 3.  Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.

Authors:  Agnieszka Anna Rucki; Lei Zheng
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

4.  Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study.

Authors:  Shay Warren; Meenal Kheterpal; Patricia L Myskowski; Alison Moskowitz; Steven M Horwitz; Melissa P Pulitzer
Journal:  J Am Acad Dermatol       Date:  2017-11-10       Impact factor: 11.527

5.  Positive effect of RORγt on the prognosis of thyroid papillary carcinoma patients combined with Hashimoto's thyroiditis.

Authors:  Rong Zeng; Yi Lyu; Guoqiao Zhang; Tao Shou; Kai Wang; Heng Niu; Xinmin Yan
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

6.  Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples.

Authors:  Simone Punt; Robert J Baatenburg de Jong; Ekaterina S Jordanova
Journal:  J Vis Exp       Date:  2017-07-29       Impact factor: 1.355

Review 7.  Impact of exercise on the immune system and outcomes in hematologic malignancies.

Authors:  Andrea Sitlinger; Danielle M Brander; David B Bartlett
Journal:  Blood Adv       Date:  2020-04-28

8.  MiR-22 regulated T cell differentiation and hepatocellular carcinoma growth by directly targeting Jarid2.

Authors:  Lian Zhang; Ping Yang; Jing Wang; Qi Liu; Tian Wang; Yaling Wang; Feng Lin
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 9.  Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

Authors:  Katherine H Parker; Daniel W Beury; Suzanne Ostrand-Rosenberg
Journal:  Adv Cancer Res       Date:  2015-05-12       Impact factor: 6.242

10.  CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.

Authors:  Chunyan Gu-Trantien; Sherene Loi; Soizic Garaud; Carole Equeter; Myriam Libin; Alexandre de Wind; Marie Ravoet; Hélène Le Buanec; Catherine Sibille; Germain Manfouo-Foutsop; Isabelle Veys; Benjamin Haibe-Kains; Sandeep K Singhal; Stefan Michiels; Françoise Rothé; Roberto Salgado; Hugues Duvillier; Michail Ignatiadis; Christine Desmedt; Dominique Bron; Denis Larsimont; Martine Piccart; Christos Sotiriou; Karen Willard-Gallo
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.